| Microglia purinoceptor P2Y6: an emerging therapeutic target in CNS diseases S Anwar, V Pons, S Rivest Cells 9 (7), 1595, 2020 | 39 | 2020 |
| Conditional genetic deletion of CSF1 receptor in microglia ameliorates the physiopathology of Alzheimer’s disease V Pons, P Lévesque, MM Plante, S Rivest Alzheimer's Research & Therapy 13, 1-15, 2021 | 37 | 2021 |
| New therapeutic avenues of mCSF for brain diseases and injuries V Pons, S Rivest Frontiers in Cellular Neuroscience 12, 499, 2018 | 35 | 2018 |
| Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease V Pons, S Rivest Pharmacological Reviews 74 (1), 1-17, 2022 | 32 | 2022 |
| Role of macrophage colony-stimulating factor receptor on the proliferation and survival of microglia following systemic nerve and cuprizone-induced injuries V Pons, N Laflamme, P Préfontaine, S Rivest Frontiers in Immunology 11, 47, 2020 | 27 | 2020 |
| Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner. S Lecordier, V Pons, S Rivest, A ElAli Frontiers in Immunology 12, 813536-813536, 2021 | 25 | 2021 |
| Beneficial roles of microglia and growth factors in MS, a brief review V Pons, S Rivest Frontiers in Cellular Neuroscience 14, 284, 2020 | 23 | 2020 |
| Muramyl dipeptide administration delays Alzheimer’s disease physiopathology via NOD2 receptors PA Piec, V Pons, P Préfontaine, S Rivest Cells 11 (14), 2241, 2022 | 8 | 2022 |
| Inhibiting nighttime melatonin and boosting cortisol increase patrolling monocytes, phagocytosis, and myelination in a murine model of multiple sclerosis M Ghareghani, V Pons, N Laflamme, K Zibara, S Rivest Experimental & Molecular Medicine 55 (1), 215-227, 2023 | 6 | 2023 |
| Triggering innate immune receptors as new therapies in Alzheimer’s disease and multiple sclerosis PA Piec, V Pons, S Rivest Cells 10 (8), 2164, 2021 | 6 | 2021 |
| The Intellicage system provides a reproducible and standardized method to assess behavioral changes in cuprizone-induced demyelination mouse model G Cisbani, S Poggini, N Laflamme, V Pons, MÈ Tremblay, I Branchi, ... Behavioural brain research 400, 113039, 2021 | 5 | 2021 |
| Author Correction: Inhibiting nighttime melatonin and boosting cortisol increase patrolling monocytes, phagocytosis, and myelination in a murine model of multiple sclerosis M Ghareghani, V Pons, N Laflamme, K Zibara, S Rivest Experimental & Molecular Medicine 55 (2), 485-486, 2023 | 1 | 2023 |
| Herpes Simplex Virus 1 Infection Does Not Increase Amyloid-β Pathology in APP/PS1 Mice L Lapeyre, J Piret, C Rhéaume, V Pons, O Uyar, P Préfontaine, S Rivest, ... Journal of Alzheimer's Disease, 1-8, 2024 | | 2024 |
Pierre-Alexandre PiecThe Jackson Laboratory在 jax.org 的电子邮件经过验证
Pierre-Alexandre PiecThe Jackson Laboratory在 jax.org 的电子邮件经过验证